| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |